Microchips in Medicine: Current and Future Applications
Table 1
Market model, insulin for types 1 and 2 diabetes. Diabetes statistics providing estimates for population sizes were collected from the American diabetes association [31].
Microchips in insulin delivery for types 1 & 2 diabetes for Company X
US diabetes type 1 prevalence (millions)
1.75
US diabetes type 2 prevalence (millions)
21
Total (millions)
22.75
Annual increase in diabetes population (millions)
1.4
Annual decrease in diabetes population (millions) (mortality rate diabetes prevalence)
0.2418
Annual increase in prevalence (millions)
1.1582
Delivery methods
Insulin only
14%
Oral only
56.90%
Insulin & oral
14.40%
Other
14.70%
Total on insulin
28.40%
Insulin only refers to both pump and syringe treatments
Average conversion rate to microchip therapy
Insulin only
25.00%
Oral only
10.00%
Insulin & oral
17.50%
Other
2.50%
Percentage of population on microchip
12.0775%
Pricing of microchip therapy (2015 dollars)
Annual per patient cost
10,000
Based upon top line pricing of insulin pump treatments & insertion procedures
Raw peak sales
Year 2035 (millions)
55,452.63
Accounting for increase in patient population size
